Home » Authors » James Etheridge

Articles by James Etheridge

NicOx, Merck Sign Exclusive Antihypertensive Drug Deal

March 22, 2006

By James Etheridge

Once Profitable, Flamel Now Losing Money: $27M In 2005

March 15, 2006

By James Etheridge

Once Profitable, Flamel Now Losing Money: $27M In 2005

March 15, 2006

By James Etheridge

Cytomics Systems Secures €10M In Series B Financing

March 1, 2006

By James Etheridge

Cytomics Systems Secures €10M In Series B Financing

March 1, 2006

By James Etheridge

No Abstract

Despite Reluctance, France Drafts Bill Covering GMOs

Feb. 22, 2006

By James Etheridge

Despite Reluctance, France Drafts Bill Covering GMOs

Feb. 22, 2006

By James Etheridge

MAT BioPharma, Pierre Fabre Enter Antibody Collaboration

Feb. 15, 2006

By James Etheridge

Hybrigenics Gains Rights To Theramex’s Inecalcitol

Feb. 15, 2006

By James Etheridge

Created: Public-Private Fund For Early Investing In France

Feb. 15, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 13, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 13, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Keros stock wilts as it halts two dosing arms in hypertension study
BioWorld
After Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study in pulmonary arterial hypertension, the company’s stock crumpled after...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.